SeaSpine Holdings Corporation provided preliminary unaudited revenue guidance for the fourth quarter and year ended December 31, 2015 and for the full year of 2016. Preliminary and unaudited revenue for the fourth quarter of 2015 is expected to be approximately $35 million, essentially flat compared to the prior year period and continuing the trend of reversing the multi-year declines reported before the spin-off. Based on this preliminary estimate, revenue from Spinal Fusion Hardware products is expected to be approximately $17 million and revenue from Orthobiologics is expected to be approximately $18 million, both essentially flat compared to the prior year period. Compared to the fourth quarter of 2014, total U.S. revenue is expected to increase 2% to approximately $31 million, with U.S. Spinal Fusion Hardware product revenue expected to increase approximately 1% and U.S. Orthobiologics product revenue expected to increase approximately 2%.

For the full year of 2015, revenue is expected to be approximately $133.5 million.

The company expects full year of 2016 revenue to be in a range of $136 million to $140 million, reflecting 2% to 5%
growth over full year of 2015 revenue.